Dr. Karla Lissette Miller, MD

Dr. Miller practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Miller's NPI, 1861671059, was assigned on October 24, 2007. Dr. Miller graduated from University of New Mexico School of Medicine in 2003. Dr. Miller holds Utah license 5756993-1205.

Dr. Miller's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Miller's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Miller is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Miller to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Miller's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miller practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Miller's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Miller is licensed in Utah.

CMS data shows 399 Medicare services from Dr. Miller across 3 procedure codes in 2024, for 132 Medicare patients. Medicare paid $19,247 for them. Every service was in an office.

CMS counts 132 Medicare patients who saw Dr. Miller in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have arthritis, and 68% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miller's median patient age at 63, with 66% women.

In 2024, Dr. Miller wrote 883 Medicare Part D claims for 121 patients. 77% of them were for generic drugs. CMS names the drug for 737 of them, across 21 drugs with 11 or more claims each, at $653,066 in total drug cost. In 2023, CMS named 662 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Miller for performance year 2024, reported as part of a group. Dr. Miller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Miller as offering telehealth.

Dmand AI links 24 papers to Dr. Miller, published from 2008 to 2025. 2015 was the busiest year, with 4. The most frequent topics are Osteoporosis, Absorptiometry, Photon and Arthritis, Rheumatoid. Dr. Miller has published most often in Osteoporos Int. Dr. Miller's most frequent co-authors are Grant Wilson Cannon, MD, Daniel O. Clegg, MD and Mark R. Elstad, MD.

CMS Open Payments shows 3 general payments to Dr. Miller from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $250.

Dr. Miller graduated from University of New Mexico School of Medicine in 2003.